CDH1 and cancer: While the expression of these EMT drivers have been well studied in many cancers, in OSCC this process has largely been defined by CDH1 switching (from E-cadherin to N-cadherin), and information regarding expression patterns of other EMT markers including the EMT transcription factors in OSCC is limited.